185 related articles for article (PubMed ID: 32358016)
1. Population Differentiation at the PVT1 Gene Locus: Implications for Prostate Cancer.
Pal G; Di L; Orunmuyi A; Olapade-Olaopa EO; Qiu W; Ogunwobi OO
G3 (Bethesda); 2020 Jul; 10(7):2257-2264. PubMed ID: 32358016
[TBL] [Abstract][Full Text] [Related]
2. Copy number-based quantification assay for non-invasive detection of PVT1-derived transcripts.
Pal G; Ogunwobi OO
PLoS One; 2019; 14(12):e0226620. PubMed ID: 31877167
[TBL] [Abstract][Full Text] [Related]
3. Long Noncoding RNA from PVT1 Exon 9 Is Overexpressed in Prostate Cancer and Induces Malignant Transformation and Castration Resistance in Prostate Epithelial Cells.
Pal G; Huaman J; Levine F; Orunmuyi A; Olapade-Olaopa EO; Onagoruwa OT; Ogunwobi OO
Genes (Basel); 2019 Nov; 10(12):. PubMed ID: 31766781
[TBL] [Abstract][Full Text] [Related]
4. PVT1 Exon 9: A Potential Biomarker of Aggressive Prostate Cancer?
Ilboudo A; Chouhan J; McNeil BK; Osborne JR; Ogunwobi OO
Int J Environ Res Public Health; 2015 Dec; 13(1):ijerph13010012. PubMed ID: 26703666
[TBL] [Abstract][Full Text] [Related]
5. N
Chen B; Liu C; Long H; Bai G; Zhu Y; Xu H
Int J Oncol; 2023 Jan; 62(1):. PubMed ID: 36484368
[TBL] [Abstract][Full Text] [Related]
6. Long Noncoding RNA PVT1 Promotes Prostate Cancer Metastasis by Increasing NOP2 Expression via Targeting Tumor Suppressor MicroRNAs.
Sun F; Wu K; Yao Z; Mu X; Zheng Z; Sun M; Wang Y; Liu Z; Zhu Y
Onco Targets Ther; 2020; 13():6755-6765. PubMed ID: 32764963
[TBL] [Abstract][Full Text] [Related]
7. LncRNA PVT1 predicts prognosis and regulates tumor growth in prostate cancer.
Yang J; Li C; Mudd A; Gu X
Biosci Biotechnol Biochem; 2017 Dec; 81(12):2301-2306. PubMed ID: 29050519
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA PVT1 promotes EMT via mediating microRNA-186 targeting of Twist1 in prostate cancer.
Chang Z; Cui J; Song Y
Gene; 2018 May; 654():36-42. PubMed ID: 29452232
[TBL] [Abstract][Full Text] [Related]
9. A rare variant of African ancestry activates 8q24 lncRNA hub by modulating cancer associated enhancer.
Walavalkar K; Saravanan B; Singh AK; Jayani RS; Nair A; Farooq U; Islam Z; Soota D; Mann R; Shivaprasad PV; Freedman ML; Sabarinathan R; Haiman CA; Notani D
Nat Commun; 2020 Jul; 11(1):3598. PubMed ID: 32680982
[TBL] [Abstract][Full Text] [Related]
10. The long non-coding RNA PVT1/miR-145-5p/ITGB8 axis regulates cell proliferation, apoptosis, migration and invasion in non-small cell lung cancer cells.
Wei CM; Zhao XF; Qiu HB; Ming Z; Liu K; Yan J
Neoplasma; 2020 Jul; 67(4):802-812. PubMed ID: 32202906
[TBL] [Abstract][Full Text] [Related]
11. Prostac: A New Composite Score With Potential Predictive Value in Prostate Cancer.
Asante-Asamani EO; Pal G; Liu L; Ogunwobi OO
Front Oncol; 2021; 11():644665. PubMed ID: 33796469
[TBL] [Abstract][Full Text] [Related]
12. Linear and circular PVT1 in hematological malignancies and immune response: two faces of the same coin.
Ghetti M; Vannini I; Storlazzi CT; Martinelli G; Simonetti G
Mol Cancer; 2020 Mar; 19(1):69. PubMed ID: 32228602
[TBL] [Abstract][Full Text] [Related]
13. Long non‑coding RNA plasmacytoma variant translocation 1 gene promotes the development of cervical cancer via the NF‑κB pathway.
Wang C; Zou H; Yang H; Wang L; Chu H; Jiao J; Wang Y; Chen A
Mol Med Rep; 2019 Sep; 20(3):2433-2440. PubMed ID: 31322217
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA plasmacytoma variant translocation 1 promotes progression of colorectal cancer by sponging microRNA-152-3p and regulating E2F3/MAPK8 signaling.
Liu X; Li L; Bai J; Li L; Fan J; Fu Z; Liu J
Cancer Sci; 2022 Jan; 113(1):109-119. PubMed ID: 34418232
[TBL] [Abstract][Full Text] [Related]
15. Long-Chain Noncoding RNA
Zhang L; Mao J
Genet Test Mol Biomarkers; 2019 Oct; 23(10):728-736. PubMed ID: 31509024
[No Abstract] [Full Text] [Related]
16. [Effects of Long Non-coding RNA Plasmacytoma Variant Translocation 1 Gene on Inflammatory Response and Cell Migration in
Jing XH; Li LX; Han TT; Shi J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Apr; 42(2):228-235. PubMed ID: 32385030
[No Abstract] [Full Text] [Related]
17. Plasmacytoma variant translocation 1 inhibits miR-515-5p function and modulates high mobility group B3 to promote the growth of prostate cancer cells.
Zhu X; Kang J; Ma Y; Wang Q; Li W; Su J; Zhang X
Andrology; 2023 May; 11(4):641-650. PubMed ID: 36053124
[TBL] [Abstract][Full Text] [Related]
18. Plasmacytoma variant translocation 1 stabilized by EIF4A3 promoted malignant biological behaviors of lung adenocarcinoma by generating circular RNA LMNB2.
Qiu M; Chen M; Lan Z; Liu B; Xie J; Li X
Bioengineered; 2022 Apr; 13(4):10123-10140. PubMed ID: 35435126
[TBL] [Abstract][Full Text] [Related]
19. A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression.
Meyer KB; Maia AT; O'Reilly M; Ghoussaini M; Prathalingam R; Porter-Gill P; Ambs S; Prokunina-Olsson L; Carroll J; Ponder BA
PLoS Genet; 2011 Jul; 7(7):e1002165. PubMed ID: 21814516
[TBL] [Abstract][Full Text] [Related]
20. Interactions of
Lin HY; Callan CY; Fang Z; Tung HY; Park JY
Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1067-1075. PubMed ID: 30914434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
